News

The first class of medical students at the University of Kentucky College of Medicine-Bowling Green Campus took their first steps in their medical education by participating in the campus' inaugural White Coat Ceremony.
Thirty students participated in the event held Friday, Aug. 3 at Van Meter Hall on the campus of Western Kentucky University in Bowling Green. In addition, earlier in the day, 136 students received white coats in a ceremony at the UK College of Medicine's Lexington campus at the UK Singletary Center for the Arts.

Dr. Greg Davis is a teacher — of students, of peers, of listeners and of juries. The many hats he wears have taken him around the world and back to his beloved Kentucky, all in service to the Hippocratic Oath and his chosen profession of forensic pathology.
There's a joke that pathologists are asocial, more comfortable with a microscope than with people. This is certainly not true of Davis, whose intellectual skill and facility with others make him an ideal teacher in all walks of life.

At the University for Kentucky, understanding and addressing the health needs of the people of the Commonwealth is the goal of many faculty, staff, clinicians and researchers. As a step toward improving health equity, the University of Kentucky Center for Health Equity Transformation (CHET) was established and recently approved by the UK Board of Trustees.

Ten researchers from institutions across the U.S. have been selected to participate in the American Society for Biochemistry and Molecular Biology (ASBMB) Advocacy Training Program, a rigorous six-month program aiming to produce the next generation of science advocates. Among those chosen is Aria Byrd, a doctoral candidate in the University of Kentucky College of Medicine and researcher in the Fillmore Brainson Lab.
By Loretta Stafford, UKnow
Click here for the story on UKnow

Difficulty in accessing culturally affirming and informed health care has long deterred members of the LGBTQ* community from seeking fundamental services and resources.

The Kentucky Cancer Registry (KCR) has received a $2.6 million contract from the National Cancer Institute (NCI) to continue its participation in the NCI’s Surveillance Epidemiology and End Results (SEER) program. If the NCI exercises all contract options, the contract could be worth up to $31 million over 10 years.

Department Chair
The College of Medicine seeks a dynamic academic and research driven innovative leader to serve as its next Chair for the Department of Behavioral Science and invites applications for the position.
This is a unique opportunity to build upon a strong and diverse foundation to substantially impact the behavioral health challenges facing the Commonwealth of Kentucky and beyond. Therefore, we desire a visionary Chair with an understanding of the future of behavioral science for the Commonwealth and demonstrated leadership abilities.




Luke Bradley, Janice Fernheimer and Gregory Luhan received the University of Kentucky 2018 Excellent Undergraduate Research Mentor Award.
Nearly 80 million Americans – one out of every four people – are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States.

On May 5, the Department of Ophthalmology and Visual Sciences at the University of Kentucky College of Medicine, in partnership with the Center of Excellence in Rural Health (CERH) and the Huffman & Huffman Clinic, held its first UK Global Ophthalmology (UK GO) outreach service in Hazard.

The University of Kentucky Barnstable Brown Diabetes Center held its eighth annual Obesity and Diabetes Research Day, highlighting the work of students, postdoctoral fellows and faculty from around the region. The program features presentations from nationally recognized physician-scientists, as well as researchers chosen from abstract submissions.

Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.
While FDA-approved medications are effective for treating persons with OUD, including buprenorphine, methadone and naltrexone, each has its own unique barriers that impact patient access to care.

When Dr. J. Thomas Murphy moved to the United States in 2002 to practice medicine as an anesthesiologist, he'd never even heard of the opioid drug Vicodin. Originally from Canada, Murphy completed his medical education and training at Dalhousie University in Nova Scotia before moving to Saudi Arabia to work as a cardiac anesthesiologist. When he came to the University of Kentucky, he saw the impacts of the opioid epidemic time and again in the cardiac operating room and would eventually feel called to join the fight.

The University of Kentucky Markey Cancer Center recently held its ninth annual Markey Cancer Center Research Day, highlighting the work of UK students, postdoctoral fellows and faculty from the past year.
Research Day provides an opportunity for investigators to showcase their work and also view the work of their colleagues across the campus. Markey researchers are housed all across the University, spanning eight colleges and 28 departments.

With a $4.9 million contract from the Patient-Centered Outcomes Research Institute (PCORI), the University of Kentucky will expand and improve treatment for pregnant women with opioid use disorder (OUD) in rural areas of Kentucky.

The American Academy of Pediatrics (AAP) recognized UK HealthCare's General Pediatric Clinic as a model in its implementation of early childhood screenings.
By integrating a series of standardized screenings into a child's visit, including developmental surveillance, maternal depression screenings, social determinants and family strengths, doctors, nurses and staff are able to get a more complete assessment of a child's health beyond his or her physical well-being. All pediatric providers complete the same screenings for all patients.